The Valley Desk

NCT04040894 · Expanded access

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Overall registry status Approved for marketing

Conditions Graves' Orbitopathy, Thyroid Eye Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov